Latent Tuberculosis Infection
📧 Sign up to get email alerts when something new happens for Latent Tuberculosis Infection.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2026-01-27FDA Approved: PRIFTIN — Supplemental Application (sanofi-aventis U.S. LLC)
The FDA approved a supplemental application for PRIFTIN (rifapentine) from Sanofi-Aventis U.S. LLC.
-
FDA approval · 2025-02-05FDA Approved: ISONIAZID — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for isoniazid submitted by Chartwell RX, LLC.
-
FDA approval · 2025-02-05FDA Approved: ISONIAZID — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for isoniazid submitted by Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2025-02-05FDA Approved: ISONIAZID — Supplemental Application (Marlex Pharmaceuticals, Inc.)
FDA approved a supplemental application for Isoniazid from Marlex Pharmaceuticals, approving changes to the previously approved product.
-
FDA approval · 2025-02-05FDA Approved: ISONIAZID — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for isoniazid (isoniazid) submitted by Chartwell RX, LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-01-30FDA Approved: ISONIAZID — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for isoniazid from Chartwell RX, LLC, authorizing changes to the previously approved product.
-
FDA approval · 2025-01-29FDA Approved: ISONIAZID — Supplemental Application (CMP Pharma, Inc.)
FDA approved CMP Pharma, Inc.'s supplemental application for isoniazid, updating the approved product under an abbreviated new drug applicat…
-
FDA approval · 2024-10-24FDA Approved: ISONIAZID — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for isoniazid from Teva Pharmaceuticals USA, Inc., confirming regulatory clearance for this gene…
-
FDA approval · 2021-09-13FDA Approved: RIFAMPIN — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for Rifampin (RIFAMPIN) submitted by Chartwell RX, LLC under ANDA065390.
-
FDA approval · 2020-06-09FDA Approved: PRIFTIN — Supplemental Application (sanofi-aventis U.S. LLC)
The FDA approved a supplemental application for Priftin (rifapentine) filed by Sanofi-Aventis U.S. LLC.
-
FDA approval · 2020-06-05FDA Approved: PRIFTIN — Supplemental Application (sanofi-aventis U.S. LLC)
The FDA approved a supplemental application for PRIFTIN (rifapentine) from Sanofi-US LLC, signaling regulatory approval related to a labelin…
-
FDA approval · 2015-07-01FDA Approved: PRIFTIN — Supplemental Application (sanofi-aventis U.S. LLC)
FDA approved a supplemental application for Priftin (rifapentine) by Sanofi-Aventis U.S. LLC, updating the drug’s labeling.
-
FDA approval · 2009-06-01FDA Approved: PRIFTIN — Supplemental Application (sanofi-aventis U.S. LLC)
The FDA approved a supplemental application for PRIFTIN (rifapentine) submitted by Sanofi-Aventis U.S. LLC.